title: Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology?
abstract: OBJECTIVE
  Cardiovascular disease is a major cause of mortality in end-stage renal disease patients (ESRD). The rate of elderly and polypathologic patients in ESRD is increasing. Elevated levels of C-reactive protein (CRP) have been shown to be associated with increased mortality in ESRD patients. The aim of this study was to examine whether, in elderly ESRD patients, the conventional relationship between elevated CRP and cardiovascular mortality is maintained.
  
  
  METHODS
  This prospective European cohort study included 150 ESRD patients. Data obtained at baseline included demographics, comorbidity, late referral to a nephrologist, high-sensitivity CRP, and serum albumin and hemoglobin levels. Cardiovascular events were analysed as a combined end-point.
  
  
  RESULTS
  The mean age of the cohort was 61 years (22-90), with 33.3% of patients over 70 years (75 yrs, 70-83 yrs). Forty-two patients (28.2%) experienced at least one cardiovascular event. Interaction between age over 70 years and CRP exceeding 3 mg/L was a protective factor. Patients over 70 years beginning dialysis with a CRP value <3 mg/L had a higher cardiovascular risk than those with a CRP value >3 mg/L. Multivariate analysis showed that the independent risk factors for cardiovascular events were, in the whole cohort, age over 70 years, previous cardiovascular comorbidity, and interaction between age and CRP.
  
  
  CONCLUSIONS
  This trial shows a reverse relation between cardiovascular risk in dialysis patients over 70 and CRP level. This may be a useful element in evaluating older patients before long-term dialysis.
authors.affiliation: Geriatric University Clinic, University Hospital of Grenoble, BP 217, 38043 Grenoble cedex 9, Grenoble, France. cmillet@chu-grenoble.fr
authors.forename: Claire
authors.initials: C
authors.lastname: Millet
authors.forename: Jean Luc
authors.initials: JL
authors.lastname: Bosson
authors.forename: Gilles
authors.initials: G
authors.lastname: Pernod
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Wauters
authors.forename: Pascal
authors.initials: P
authors.lastname: Couturier
authors.forename: Jean Louis
authors.initials: JL
authors.lastname: Quesada
authors.forename: Philippe
authors.initials: P
authors.lastname: Zaoui
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D002097:C-Reactive Protein / Q000032:analysis* / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000401:mortality*; D015897:Comorbidity; D005060:Europe; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D006435:Renal Dialysis / Q000379:methods; D012307:Risk Factors; D012709:Serum Albumin / Q000032:analysis; D015996:Survival Rate
chemical_list: D015415:Biomarkers; D006454:Hemoglobins; D012709:Serum Albumin; D002097:C-Reactive Protein